India  

COVID-19: Bharat Biotech submits Covaxin`s Phase III trial data to DCGI, say Govt sources

Zee News Tuesday, 22 June 2021
Bharat Biotech's phase III data of its vaccine have been questioned various times.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News

Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News 02:02

Bharat Biotech has submitted Phase 3 clinical trial data for its Covid-19 vaccine, Covaxin, to the Drug Controller General of India (DCGI). The development comes nearly five months after Covaxin was authorised for emergency usage in the country. #Covid19 #BharatBiotech #Covaxin

You Might Like


Related news from verified sources

Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt sources


IndiaTimes